Influence of GSTM1, GSTT1, GSTP1, and EPHX gene polymorphisms on DNA adduct level and HPRT mutant frequency in coke-oven workers

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 431, Issue 2, 1999, Pages 259-269

  Viezzer, Cristina ^a,b   Norppa, Hannu ^b   Clonfero, Erminio ^a   Gabbani, Gigliola ^a   Mastrangelo, Giuseppe ^a   Hirvonen, Ari ^b   Celotti, Lucia ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

DNA adducts; Genetic polymorphism; HPRT mutations; Human T lymphocytes; PAH exposure

Indexed keywords

COKE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; DNA ADDUCT; GENE DELETION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LESCH NYHAN SYNDROME; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL TOXICOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AIR POLLUTANTS, OCCUPATIONAL; DNA ADDUCTS; EPOXIDE HYDROLASES; GLUTATHIONE TRANSFERASE; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MALE; METALLURGY; MIDDLE AGED; MUTATION; OCCUPATIONAL EXPOSURE; PHARMACOGENETICS; POLYCYCLIC HYDROCARBONS, AROMATIC; POLYMORPHISM, GENETIC; SMOKING;

EID: 0033400427     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00169-4     Document Type: Article

References (43)

1. Mastrangelo M., Fadda E., Marzia V. Polycyclic Aromatic Hydrocarbons and cancer in man. Environ. Health Perspect. 104:1996;1166-1170.
2. Celotti L., Viezzer C., Pavanello S., Ferraro P., Levis A.G., Ferri G., Foà V. DNA adduct levels in peripheral blood lymphocytes of coke-oven workers. J. Clean Technol. Environ. Toxicol. Occup. Med. 5:1996;167-177.
3. Zanesi N., Mognato M., Pizzato M., Viezzer C., Ferri G., Celotti L. Determination of HPRT mutant frequency and molecular analysis of T-lymphocyte mutants derived from coke-oven workers. Mutat. Res. 412:1998;177-186.
4. Clonfero E., Granella M., Marchioro M., Leopardi Barra E., Nardini B., Ferri G., Foà V. Urinary excretion of mutagens in coke-oven workers. Carcinogenesis. 16:1995;547-554.
5. Falany C.N., McQuiddy P., Kasper C.B. Structure and organization of the microsomal xenobiotic epoxide hydrolase. J. Biol. Chem. 262:1987;5924-5930.
6. Seidegård J., Ekström G. The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ. Health Perspect. 105:1997;791-799.
7. Hassett C., Aicher L., Sidhu J.S., Omiecinski C.J. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet. 3:1994;421-428.
8. Benhamou S., Reinikainen M., Bouchardy C., Dayer P., Hirvonen A. Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res. 58:1998;5291-5293.
9. Ketterer B., Harris J.M., Talaska G., Meyer D.J., Pemble S.E., Taylor J.B., Lang N.P., Kadlubar F.F. The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ. Health Perspect. 98:1992;87-94.
10. Mannervik B., Awasthi Y.C., Board P.C., Hayes J.D., Illio C., Ketterer B., Listowsky I., Morgenstern R., Muramatsu M., Pearson W.R., Pickett C.B., Sato K., Widerstern M., Wolf C.R. Nomenclature for human glutathione transferases. Biochem. J. 282:1992;305-307.
11. Pemble S., Schroeder K.R., Spencer S.R., Meyer D.J., Hallier E., Bolt H.M., Ketterer B., Taylor J.B. Human glutathione S-transferase Theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J. 300:1994;271-276.
12. Ali-Osman F., Akande O., Antoun G., Mao J.X., Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. J. Biol. Chem. 272:1997;10004-10012.
13. Nakajima T., Elovaara E., Anttila S., Hirvonen A., Camus A.M., Hayes J.D., Ketterer B., Vainio H. Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis. 16:1995;707-711.
14. Harries L.W., Stubbins M.J., Forman D., Howard G.C.W., Wolf C.R. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 18:1997;641-644.
15. Lin H.J., Han C.Y., Bernstein D.A., Hsiao W., Lin B.K., Hardy S. Ethnic distribution of the glutathione transferase Mu 1-1(GSTM1) null genotype in 1473 individuals and application to bladder cancer. Carcinogenesis. 15:1994;1077-1081.
16. Hirvonen A. Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ. Health Perspect. 107(suppl. 1):1999;37-47.
17. Rojas M., Alexandrov K., Cascorbi I., Brockmöller J., Likhachev A., Pozharisski K., Bouvier G., Auburtin G., Mayer L., Kopp-Schneider A., Roots I., Bartsch H. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/MspI-GSTM1*0/*0 genotypes. Pharmacogenetics. 8:1998;109-118.
18. van Poppel G., de Vogel N., van Bladeren P.J., Kok F.J. Increased cytogenetic damage in smokers deficient in glutathione S-transferase isozyme μ Carcinogenesis. 13:1992;303-305.
19. van Poppel G., Verhagen H., van't Veer P., van Bladeren P.J. Markers for cytogenetic damage in smokers: associations with plasma antioxidants and glutathione S-transferase μ Cancer Epidemiol. Biom. Prevent. 2:1994;441-447.
20. Scarpato R., Hirvonen A., Migliore L., Falck G., Norppa H. Influence of GSTM1 and GSTT1 polymorphisms on the frequency of chromosome aberrations in lymphocytes of smokers and pesticide-exposed greenhouse workers. Mutat. Res. 389:1997;227-235.
21. Knudsen L.E., Norppa H., Gamborg M.O., Nielsen P.S., Okkels H., Soll-Johanning H., Raffn E., Järventaus H., Autrup H. Chromosomal aberrations induced by urban air pollution in humans: influence of DNA repair and polymorphisms of glutathione S-transferase M1 and N-acetyltransferase 2. Cancer Epidemiol. Biom. Prevent. 8:1999;303-310.
22. Gabbani G., Hou S.M., Nardini B., Marchioro M., Lambert B., Clonfero E. GSTM1 and NAT2 genotypes and urinary mutagens in coke-oven workers. Carcinogenesis. 17:1996;1677-1681.
23. Kelsey K.T., Wiencke J.K., Ward J., Bechtold W., Fajen J. Sister chromatid exchanges, glutathione S-transferase θ deletion and cytogenetic sensitivity to diepoxybutane in lymphocytes from butadiene monomer production workers. Mutat. Res. 335:1995;267-273.
24. Norppa H., Hirvonen A., Järventaus H., Uusküla M., Tasa G., Ojajärvi A., Sorsa M. Role of GSTT1 and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange induction by diepoxybutane in cultured human lymphocytes. Carcinogenesis. 16:1995;2116-2119.
25. Wiencke J.K., Pemble S., Ketterer B., Kelsey K.T. Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol. Biom. Prevent. 4:1995;254-259.
26. Landi S., Norppa H., Frenzilli G., Cipollini G., Ponzanelli I., Barale R., Hirvonen A. Individual sensitivity to cytogenetic effects of 1,2:3,4-diepoxybutane in cultured human lymphocytes: influence of glutathione S-transferase M1, P1 and T1 genotypes. Pharmacogenetics. 8:1998;461-471.
27. Rydberg D., Skaug V., Hewer A., Phillips D., Harries L.W., Wolf C.R., Øgreid D., Ulvik A., Vu P., Haugen A. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 18:1997;1285-1289.
28. Matthias C., Bockmuhl U., Jahnke V., Harries L.W., Wolf C.R., Jones P.W., Alldersea J., Worrall S.F., Hand P., Fryer A.A., Strange R.C. The glutathione S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics. 8:1998;1-6.
29. Lancaster J.M., Brownlee H.A., Bell D.A., Futreal P.A., Marks J.R., Berchuck A., Wiseman R.W., Taylor J.A. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol. Carcinogenesis. 17:1996;160-162.
30. Chen H., Sandler D.P., Taylor J.A., Shore D.L., Liu E., Bloomfield C.D., Bell D.A. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet. 347:1996;295-297.
31. Saarikoski S., Voho A., Reinikainen M., Anttila S., Karjalainen A., Malveille C., Vainio H., Husgafvel-Pursiainen K., Hirvonen A. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int. J. Cancer. 77:1998;516-521.
32. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis. 7:1986;1543-1551.
33. Albertini R.J., Castle K.L., Borcherding W.R. T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood. Proc. Natl. Acad. Sci. U.S.A. 79:1982;6617-6621.
34. Dixon W.J. BMDP Statistical Software Manual. 1992;University of California Press, Berkeley.
35. Sokal R.R., Rohlf F.J. Biometry. The Principles and Practice of Statistics in Biological Research II. 1981;Freeman, New York.
36. Pastorelli R., Guanci M., Cerri A., Negri E., La Vecchia C., Fumagalli F., Mezzetti M., Cappelli R., Panigalli T., Fanelli R., Airoldi L. Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide. Cancer Epidemiol. Biom. Prevent. 7:1998;703-709.
37. Grinberg-Funes R., Singh V.N., Perera F.P., Bell D.A., Young T.L., Dickey C., Wang L.W., Santella R. Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione S-transferase genotype. Carcinogenesis. 15:1994;2449-2454.
38. Butkiewicz D., Grybowska E., Hemminki K., Ovrebo K.S., Haugen A., Motykewicz G., Choràzy M. Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1, CYP2D6 and GSTM1 genetic polymorphisms. Mutat. Res. 415:1998;97-108.
39. Cheng T.-J., Christiani D.C., Liber H.L., Wain J.C., Xu X., Wiencke J.K., Kelsey K.T. Mutant frequency at the hprt locus in human lymphocytes in a case-control study of lung cancer. Mutat. Res. 332:1997;109-118.
40. Hou S.-M., Fält S., Steen A.-M. HPRT mutant frequency and GSTM1 genotype in non-smoking healthy individuals. Environ. Mol. Mutagen. 25:1995;97-105.
41. Lambert B., Bastlova T., Österlund A.-M., Hou S.-M. Analysis of mutation at the hprt locus in human T lymphocytes. Toxicol. Lett. 82/83:1995;323-333.
42. Nelson H.H., Wiencke J.K., Christiani D.C., Cheng T.J., Zuo Z.F., Schwartz B.S., Lee B.K., Spitz M.R., Wang M., Xu X., Kelsey K.T. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis. 16:1995;1243-1245.
43. Popp W., Vahrenholz C., Schell C., Grimmer G., Dettbarn G., Kraus R., Brauksiepe A., Schmeling B., Gutzeit T., von Low J., Norpoth K. DNA single breakage, DNA adducts, and sister chromatid exchange in lymphocytes and phenanthrene and pyrene metabolites in urine of coke-oven workers. Occup. Environ. Med. 54:1997;176-183.